8039 — TAIFLEX Scientific Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD9.63bn
- TWD10.48bn
- TWD8.15bn
- 52
- 41
- 60
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,669 | 1,962 | 3,573 | 2,322 | 1,993 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,368 | 4,237 | 4,014 | 3,730 | 3,869 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,602 | 7,582 | 9,557 | 7,913 | 7,375 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,373 | 3,558 | 3,731 | 4,287 | 4,892 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 11,374 | 11,532 | 14,075 | 12,848 | 13,031 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,296 | 2,806 | 2,935 | 2,069 | 4,103 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,128 | 4,072 | 6,310 | 4,939 | 5,044 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 7,246 | 7,460 | 7,765 | 7,908 | 7,987 |
Total Liabilities & Shareholders' Equity | 11,374 | 11,532 | 14,075 | 12,848 | 13,031 |
Total Common Shares Outstanding |